India: Patentability Of Stem Cell Technology

Stem cell technology is not a new concept having been popular since last decade. Stem cells are auto-generative cells which have the capability of indefinite division. They can easily be maintained in laboratories as cell lines. Since they can divide and differentiate to form different cells of the body, they have vast scope in medical realm with respect to repair and replacement of human tissues and a probable cure for many conventional and non-conventional diseases. There are two kinds of stem cells i.e. embryonic stem cells and adult stem cells.

Embryonic stem cells are obtained from the blastocyst stage of the human embryo, where embryo is a gestational stage in the human birth cycle. Since this extraction unfortunately makes the embryo nonviable1, this technology raises many ethical and moral concerns in the society. However, recent advancements in in-vitro fertilization and ability to derive stem cells from umbilical cord blood and amniotic cell lining2 (a biological waste after delivery of the child) have resolved majority of such issues, thus, accelerating research in the area. Deriving stem cells from umbilical cord blood is deemed more acceptable ethically, and therefore, this process has become very popular in exercising benefits out of stem cell technology. There is high awareness about the preservation of umbilical cord blood among the educated Indians and it has gained popularity with a number of stem cell banks, both public and private, facilitating cryopreservation of stem cells in India.

On the other hand, working with adult stem cells is comparatively easier since the process does not require invasion of the source from which it is taken. Adult stem cells can be obtained mainly through three sources i.e. bone marrow, adipose tissue and blood. Functionality of adult stem cells has been found to be very limited as compared to the functionality of embryonic stem cells. Therefore, majority of the therapeutic researches involve human embryonic cell lines.

Embryonic stem cells are considered to be pluripotent cells i.e. they have the ability to develop into different cell types of the human body. Embryonic cells can even be totipotent if they are obtained from a very young embryo which has undergone only a few cycles of cell division. Such cells, in addition to being pluripotent, have the ability to get differentiated into extraembryonic and placental cells. Adult stem cells have the capability of regenerating only similar or related tissues from which they are derived and therefore, have limited applicability.3 Such cells are known to exhibit multipotent characteristics but have limited scope compared to pluripotent cells.

Application of stem cells lies primarily in utilizing their pluripotent and totipotent characters in repair and replacement of tissues. Technology for making patient specific stem cells, and tissues thereof, has been developed. This ensures the repair and/or replacement offered by such tissues a better probability of getting accepted by the immune system of the body4. This therapeutic aspect of stem cells finds benefit in curing various malignant and non-malignant diseases like diabetes, Parkinson's disease, cancer etc.

Different countries have different countenance about this technology as a breakthrough in medical science. Some countries offer full support to researchers to explore this field to the fullest extent, whereas in some others there are no formal policies resulting in the majority of research being governed by private contributors without the support of the government. The countries' acceptance of this technology shows their clear preference toward therapeutic benefits of stem cells over the concerned ethical issues. Countries supporting this technology include United Kingdom, Belgium, Israel, South Korea, India, Japan, Singapore, China and Australia. Other countries like Germany, Austria and Italy offer stricter policies for stem cell research. Some other countries like United States, Canada, European Union, however have limited opportunities which can be availed only if the research is deemed ethically acceptable.

It is to be noted that the majority of the countries, irrespective of whether they support stem cell research or not, exploit this technology only for therapeutic purposes, while cell cloning is highly restrained being used just for the purpose of research. Most research is carried out ethically by either exploiting the embryos that are deemed to be a waste after in-vitro fertilization, or those embryos that are unwanted or sacrificed; or stem cells derived from umbilical cord blood.


Just like policy framework, patentability of this kind of research is also highly varied among different countries. For an invention to be patentable, it should suffice three basic requirements of i) novelty, ii) non-inventiveness and iii) industrial applicability. Invention related to stem cell technology generally qualifies these requirements and becomes a patentable subject matter. The Indian Patents Act (1970) says that an application should also qualify criteria given under section 3, for it to be considered as an invention. Stem cell technology falls under the purview of 3(b) of the Act, according to which 'an invention, the primary or intended use or commercial exploitation of which could be contrary public order or morality or which cause serious prejudice to human, animal or plant life or health or to the environment, are not inventions'.

Whether the stem cell technology should be considered non-ethical or against moral values, vis-à-vis the various benefits it offers to those who do not have any other cure, is a debatable topic, which keeps recurring between the researchers and the policy makers.

As far as India and most of the other countries are concerned, they have voted for technology only in case ethical ways are used to derive embryonic stem cells. These ethical ways, as reported by the researchers, like using human embryos, produced by in-vitro fertilization, aborted fetuses, and asexually produced human embryos for deriving such cells, are not against public order or morality in any way5. India is lucky in a way that the government is supporting researchers in this area for the good of the nation. In addition, nothing has been mentioned in Patents Act (1970) which makes stem cell and related research not patentable. Therefore, stem cell technology is considered patentable, and a good number of patent applications are made every year and several are granted6 to bring in optimistic competition among the researchers.

It will not be wrong to say that stem cell research is a very promising field and can prove to be a boon for biotechnology sector of the country. Research in this field should be encouraged by giving suitable intellectual property rights to such inventions.


1. The Limits of Patentability: Stem Cells. Available at:

2. Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues. Available at: https://

3. What is the difference between totipotent, pluripotent, and multipotent? Available at:

4. The patentability of stem cells, reforms to patent law. Available at:

5. Patent: Stem Cell Patent Debate Never Dies. Available at:

6. ibid

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions